WISE Finance Valuation

Is IBS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IBS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate IBS's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate IBS's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for IBS?

Key metric: As IBS is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for IBS. This is calculated by dividing IBS's market cap by their current earnings.
What is IBS's PE Ratio?
PE Ratio	2.8x
Earnings	zł12.07m
Market Cap	zł33.26m

IBS key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	5.9x
Enterprise Value/EBITDA	122.4x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does IBS's PE Ratio compare to its peers?

The above table shows the PE ratio for IBS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	6x
EFK Korporacja Gospodarcza efekt	0.8x	n/a	zł35.0m
CAV Cavatina Holding Spólka Akcyjna	3.2x	n/a	zł325.5m
CFI CFI Holding	10.5x	n/a	zł440.1m
MLG MLP Group	9.6x	16.5%	zł1.8b
IBS WISE Finance	2.8x	n/a	zł33.3m

Price-To-Earnings vs Peers: IBS is good value based on its Price-To-Earnings Ratio (2.8x) compared to the peer average (6x).

Price to Earnings Ratio vs Industry

How does IBS's PE Ratio compare vs other companies in the PL Real Estate Industry?

3 Companies	Price / Earnings	Estimated Growth	Market Cap
ATL Atlas Estates	0.8x	n/a	US$13.35m
EFK Korporacja Gospodarcza efekt	0.8x	n/a	US$8.50m
CPD CPD	0.1x	n/a	US$1.90m

No more companies available in this PE range

3 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: IBS is good value based on its Price-To-Earnings Ratio (2.8x) compared to the Polish Real Estate industry average (8.8x).

Price to Earnings Ratio vs Fair Ratio

What is IBS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IBS PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	2.8x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate IBS's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Korporacja Gospodarcza efekt

zł35.0m

Engages in the provision of rental and tenancy services for premises and commercial stands.

EFK

zł7.00

4.5%

Rank Progress

zł245.2m

Invests in, develops, rents, and sells commercial real estate properties in Poland and internationally.

RNK

zł6.86

-2.8%

211.8%

ED Invest Spólka Akcyjna

zł63.1m

Develops residential and service apartments in Poland.

EDI

zł6.34

0.6%

-34.0%